fr

Inscription
Tout investissement comporte des risques et ne convient pas à tout le monde.
Accueil・Liste d'Actions・Laboratorios Farmaceuticos Rovi SA
Search

Laboratorios Farmaceuticos Rovi SA

Fermé

80.2 1.84

Achat

Actualisation du prix 6 sept. 2024, 15:29 UTC

AcheterVendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

80.15

Max

80.45

Chiffres clés

By Trading Economics

Revenu

15M

Ventes

-297M

151M

P/E

Moyenne du Secteur

24.61

BPA

0.292

Marge bénéficiaire

9.896

EBITDA

26M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+22.52 upside

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-23M

4.1B

Ouverture précédente

78.36

Clôture précédente

80.2

Sentiment de l'Actualité

By Acuity

63%

37%

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

78.2 / N/A Support & Résistance

Laboratorios Farmaceuticos Rovi SA Graphique

Actualités Associées

6 sept. 2024, 22:41 UTC

Market Talk

KinderCare and StandardAero File for IPOs -- Market Talk

DJ

Lire

6 sept. 2024, 21:18 UTC

Actualités

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- Update

DJ

Lire

6 sept. 2024, 21:05 UTC

Actualités

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 4th Update

DJ

Lire

6 sept. 2024, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Lire

6 sept. 2024, 20:39 UTC

Résultats

Update: NIO Stock Caught an Upgrade. Shares Rose. -- Barrons.com

DJ

Lire

6 sept. 2024, 20:35 UTC

Actualités

Stocks Extend Ugly Week of Losses Amid Economic Uncertainty -- WSJ

DJ

Lire

6 sept. 2024, 20:34 UTC

Actualités

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- 3rd Update

DJ

Lire

6 sept. 2024, 20:11 UTC

Actualités

Stock Indexes Close Lower After Mixed Jobs Report -- WSJ

DJ

Lire

6 sept. 2024, 19:51 UTC

Actualités

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- WSJ

DJ

Lire

6 sept. 2024, 19:16 UTC

Market Talk

U.S. Natural Gas Futures Hold Gains -- Market Talk

DJ

Lire

6 sept. 2024, 19:14 UTC

Market Talk

Oil Futures Extend Losses on Demand Concerns -- Market Talk

DJ

Lire

6 sept. 2024, 19:01 UTC

Market Talk

Gold Slips on Prevailing Uncertainty -- Market Talk

DJ

Lire

6 sept. 2024, 18:27 UTC

Actualités

JPMorgan Plans to Report Customers Who Exploited TikTok 'Glitch' to Authorities -- WSJ

DJ

Lire

6 sept. 2024, 18:25 UTC

Market Talk

Broadcom Growth Views Conservative Amid AI Investments -- Market Talk

DJ

Lire

6 sept. 2024, 18:15 UTC

Actualités

U.S. Tells Allies Iran Has Sent Ballistic Missiles to Russia, European and U.S. Officials Say -- Update

DJ

Lire

6 sept. 2024, 18:12 UTC

Actualités

Nasdaq Falls 2.5%, Leads Losses After Mixed Jobs Report -- WSJ

DJ

Lire

6 sept. 2024, 17:44 UTC

Market Talk

Labor Costs Represent Diminishing Risk To Canada CPI, CIBC's Shenfeld Says -- Market Talk

DJ

Lire

6 sept. 2024, 17:30 UTC

Market Talk

U.S Oil Rig Count Unchanged at 483 -- Market Talk

DJ

Lire

6 sept. 2024, 17:30 UTC

Actualités

Boeing's Starliner Is Returning to Earth Without Its Crew -- WSJ

DJ

Lire

6 sept. 2024, 17:27 UTC

Actualités

Hiring Softened This Summer, Teeing Up Fed Rate Cuts -- WSJ

DJ

Lire

6 sept. 2024, 17:00 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lire

6 sept. 2024, 17:00 UTC

Market Talk

Mexican Inflation Seen Easing in August -- Market Talk

DJ

Lire

6 sept. 2024, 16:36 UTC

Market Talk

Oil Futures Fall as U.S. Jobs Report Sinks In -- Market Talk

DJ

Lire

6 sept. 2024, 16:35 UTC

Résultats
Actions en Tendance

Stocks to Watch Friday: Broadcom, Nvidia, UiPath, Smith & Wesson -- WSJ

DJ

Lire

6 sept. 2024, 16:33 UTC

Acquisitions, Fusions, Rachats

Salesforce Stock Is on Pace for Longest Losing Streak Since 2008. An Acquisition Isn't Helping. -- Barrons.com

DJ

Lire

6 sept. 2024, 16:20 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

DJ

Lire

6 sept. 2024, 16:20 UTC

Résultats

Oracle Profit, Revenue Set to Rise in 1Q -- Earnings Preview

DJ

Lire

6 sept. 2024, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Lire

6 sept. 2024, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Lire

6 sept. 2024, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

DJ

Lire

Laboratorios Farmaceuticos Rovi SA prévision

Objectif de Prix

By TipRanks

22.52% hausse

Prévisions sur 12 Mois

Moyen 99 EUR  22.52%

Haut 104 EUR

Bas 94 EUR

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

2 ratings

2

Achat

0

Maintien

0

Vente

Basé sur 2 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

78.2 / N/ASupport & Résistance

Court Terme

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Moyen Terme

Bearish Evidence

Bearish events outweigh bullish events.

Long Terme

Weak Bullish Evidence

All events are bullish.

Sentiment

By Acuity

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

$

À Propos Laboratorios Farmaceuticos Rovi SA

Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast mediums for use in magnetic resonance, ultrasound and X-ray diagnostics; Prescription, which distributes medicines under such brands as Hibor, Osseor, Hepadren, Pneumovax-23, Glufan, Corlentor, Exxiv, Calcio y Vitamina D3 Rovi and Absorcol, among others; and Over The Counter (OTC), which comprises the Perspirex, Enerzona, Dentimelo and ColdPack brands. The Company owns such fully consolidated subsidiaries as Gineladius SL, Frosst Iberica SA, Rovi Contract Manufacturing SL and Bertex Pharma GmbH, among others.